Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 3 2

Status

Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 106Carcinoma, Intraductal, Noninfiltrating 6Neoplasms 4Neoplasm Metastasis 3Breast Neoplasms, Male 3Breast Diseases 3Breast Carcinoma In Situ 3Triple Negative Breast Neoplasms 2Ovarian Neoplasms 2Endometrial Neoplasms 2Breast Cancer Metastatic 2Sexual Dysfunction, Physiological 1Seizures 1Multiple Endocrine Neoplasia Type 1 1Locoregional Recurrence 1Lethal Congenital Contracture Syndrome 2 1Inflammatory Breast Neoplasms 1Hypogonadism 1Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1HER2-positive Breast Cancer 1HER2 Negative Breast Cancer 1Granulosa Cell Ovarian Cancer 1Fallopian Tube Neoplasms 1Erectile Dysfunction 1Epilepsy 1Endometrial Stromal Tumors 1ER+ Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1Bulbo-Spinal Atrophy, X-Linked 1Breast Neoplasm Female 1

Interventions

Cyclophosphamide 17Trastuzumab 16Paclitaxel 15Doxorubicin 11Docetaxel 10Radiotherapy 9Carboplatin 9Capecitabine 9Bevacizumab 8Lapatinib 7Taxes 6Tamoxifen 6Gemcitabine 5Filgrastim 5Chemotherapy, Adjuvant 5sargramostim 4Sorafenib 4Radiation 4Neoadjuvant Therapy 4Granulocyte-Macrophage Colony-Stimulating Factor 4Vinorelbine 3Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Irinotecan 3Immunohistochemistry 3Granulocyte Colony-Stimulating Factor 3Erlotinib Hydrochloride 3Anastrozole 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms, Male × Anastrozole × Clear all
NCT05501704 2026-04-30

ETHAN - ET for Male BC

Dana-Farber Cancer Institute

Phase 2 Recruiting
60 enrolled
Breast

Breast Neoplasms, Male

NCT01394211 2018-07-26

Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer

University of Arizona

Phase 2 Terminated
2 enrolled 3 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00217659 2013-01-03

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

SWOG Cancer Research Network

Phase 2 Withdrawn
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡